Low-Acid Food Diet

Watermelon is at the top of the list of the Low Acid Diet

Each individual’s “bio-chemistry and predisposition” to disease is unique and  are continuously being explored in the medical world. While a new diet is not designed to be a monthly fad, the Low Acid Diet can be applied to most individuals, especially those who may combat stomach discomfort.

The normal bodily pH of 7.35- to 7.45 keeps our bodies in homeostasis. Water has a neutral pH 7; all  foods and beverages can then labeled as more basic, for numbers higher than pH 7, or they maybe be classified as acidic, for numbers are lower than pH 7.

The Low-Acid Diet has benefited: weight loss, treats those suffer from Acid Reflux, GERD, curves Osteoporosis, and improves Laryngopharyngeal Reflux. This diet is safe for those who like to change their dietary routine and/or introduce some new foods into there meals or snacks.

A salad with the Low Acid Diet ingredients can benefit anyone!

Watermelon ranks the highest on the list of basic nutrition, other foods are: beans, nuts, olive oil, lettuce, celery, broccoli and grapefruit.  Interestingly, many of these foods are also contributors to keeping the liver healthy by synthesizing bile salts and secreting bile acid so that toxins do not build in the body and regular bowel movements occur daily. Those who suffer from IBS will also be able to follow this diet.

Complete nutrition includes both basic and acidic foods and should be a part of 3 square meals. Acidic foods have been listed as the following, consume in moderation: processed foods, coffee, alcohol and animal proteins found in dairy products, red meats, chicken, fish.

Researchers have explored acidic food’s impact on bone health, having shown that “dairy products do not have a negative impact on bone health”, Department of Community and Health Sciences, University and Calgary, Canada; confirmed by Researchers at Grand Forks Human Nutrition Research Center.

In conclusion, all foods can be eaten in controlled amounts, those with specific needs should review individual concerns with your doctor or dietitian before adjusting your dietary intake.

By: Kimberly Crocker- Scardicchio

Additional Reading at Eat Know How:
Fennel Seeds to Soothe and Restore Health
Fast Food: Fatty Liver
Gas Pains, Drink Lemon Water

Visit Recipes for ideas on how to supplement your meals.
Fava Bean Soup
Vegetable Couscous
Lentil Soup with Natures Cure

Reference

Recommended Daily Intake of Vitamins & Minerals

Recommended daily intake of vitamins and minerals and actual breakdown of Vitamin Content for Vegetables and Fruits with a glance at Mineral Content on Fruit and Vegetables Informative links that nicely graphs the proper milligrams of vitamins and minerals that should be ingested on a day to day basis with warnings about how they may create organ sensitivity or organ damage.

Eat Know How.  Know the Healing Power of Food

Recommended link: Vitamins and Minerals

“Hold the garlic butter”, FDA warns, “Lobster’s contaminated”

NEWS

New Food Warning….

FDA is warning consumers to avoid eating tomalley in American lobster (also called Maine lobster), regardless of where the lobster was harvested, because of potential contamination with dangerous levels of the toxins that cause paralytic shellfish poisoning (PSP). These types of   lobster are harvested from the Atlantic Ocean from Northeastern Canada to South Carolina . The FDA advisory applies only to tomalley the soft, green substance found in the body cavity of the lobster that functions as the liver and pancreas. Cooking does not eliminate the PSP toxins. 

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01866.html  

 

New Type of Genetic Test Approved for Breast Cancer Patients

FDA has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab). The SPOT-Light HER2 CISH test kit measures the number of copies of the HER2 gene in tumor tissue. This gene regulates the growth of cancer cells.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01857.html 

 

FDA Requests Stronger Warnings on Fluoroquinolone Antimicrobial Drugs

FDA has notified makers of fluoroquinolone antimicrobial drugs that a “boxed warning in the product labeling concerning the increased risk of tendinitis and tendon rupture is necessary and a guide must be made available to patients that explains possible side effects. Fluoroquinolones are approved to treat or prevent certain bacterial infections.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01858.html

Pharmaceuticals Gets Flagged

Xiadafil VIP Tablets Seized After Company Refuses to Recall Product

U.S. marshals have seized nearly $74,000 worth of Xiadafil VIP tablets (lots 6K029 and 6K209-SEI) distributed by Florida-based SEI Pharmaceuticals Inc. Although this product is marketed as a dietary supplement to treat erectile dysfunction and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01864.html 

Consumer Health Information

› Are You Storing Food Safely?

http://www.fda.gov/consumer/updates/foodstorage072108.html

Making Sense of Vytorin Concerns

http://www.fda.gov/consumer/updates/vytorin071808.html

SAFETY ALERTS/RECALLS

  For a list of recalls, market withdrawals, and safety alerts involving FDA-regulated

products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html. 

 

 

 

FDA Revises Process for Responding to Drug Applications

FDA is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted. The agency will no longer issue “approvable” or “not approvable” letters when a drug application is not approved. Instead, it will issue a “complete response” letter that lets a company know the review period for a drug is complete and that the application is not yet ready for approval. The letter will describe deficiencies and, when possible, will outline recommended actions the applicant might take to get the application ready for approval.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01859.html</

FDA News Rx Drugs used during Pregnancy & Breast Feeding, Food Recall, Albuterol Inhalers

FDA News Digest

June 2, 2008 ___________________________________

IN THIS WEEK’S ISSUE

»  News

    — Labeling Changes Proposed for Rx Drugs Used During Pregnancy, Breastfeeding

    — FDA Patient Safety News’ Video, Podcast Available

»  Safety Alerts/Recalls

»  Upcoming Public Meetings

»  Consumer Health Information

__________________________________________

NEWS

 

Labeling Changes Proposed for Rx Drugs Used During Pregnancy, Breastfeeding

FDA has proposed major revisions to physician labeling for prescription drugs (including biological products) to provide better information about the effects of medicines used during pregnancy and breastfeeding. The changes would give health care professionals more comprehensive information for making prescribing decisions and for counseling women about using prescription medications if they are pregnant, breastfeeding, or of childbearing age.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01841.html

 

‘FDA Patient Safety News’ Video, Podcast Available

FDA has posted the latest edition of “FDA Patient Safety News,” a free Web-based video news program. Aimed primarily at health professionals, the program features information on new drugs, biologics, and medical devices, as well as FDA safety notifications and product recalls.

To view video or text version: http://www.fda.gov/psn

To access Podcast: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/podcast.cfm    

To access the RSS feed of FDA news releases, go to

http://www.fda.gov/bbs/topics/news/rssPress.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

_____________________________________________

 

SAFETY ALERTS/RECALLS

Food Recall:

  Certain lots of Amish Macaroni Salad under the Orval Kent or Yoder’s label (various sizes)

Reason for recall: a precaution due to results of tests on a single package for E. coli O157:H7

http://www.fda.gov/oc/po/firmrecalls/orvalkent05_08.html

  ____________________________________________________________________

 

UPCOMING PUBLIC MEETINGS

 

June 9Pediatric Ethics Subcommittee of the Pediatric Advisory Committee

    Under discussion: regulations applying to clinical investigations involving greater than minimal risk but presenting possible direct patient benefit

    Location: Gaithersburg, Md.

http://edocket.access.gpo.gov/2008/E8-8352.htm

 

June 10Ophthalmic Devices Panel of the Medical Devices Advisory Committee

    Under discussion: postmarket experience with various contact lens care products

    Location: Gaithersburg, Md.

http://edocket.access.gpo.gov/2008/E8-11451.htm

 

June 12Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee

    Under discussion: pending application to market a surgical sealant

    Location: Gaithersburg, md.

http://edocket.access.gpo.gov/2008/E8-9537.htm

 

For a complete list of upcoming meetings, seminars, and other public events sponsored

or co-sponsored by FDA, go to http://www.fda.gov/opacom/hpmeetings.html.

 

CONSUMER HEALTH INFORMATION

 

Note to readers “Start at the Store: 7 Ways to Prevent Food-borne Illness.” http://www.fda.gov/consumer/updates/foodillness051308.html.

 

›  Albuterol Inhalers: Time to Transition

http://www.fda.gov/consumer/updates/albuterol053008.html

›  Sentinel System to Monitor Medical Product Safety

http://www.fda.gov/consumer/updates/sentinel052208.html

 

FDA News: Violations of Food Safety Laws Closes Cream Cheese, Seafood & Cough/Cold Operations

FDA News Digest

May 19, 2008 _______________________________

IN THIS WEEK’S ISSUE

»  News

    — Cream Cheese, Seafood Operations Closed Following Repeat Violations

    — Texas Seafood Processor Ordered to Shut Down, Recall Products

    — Maker, Distributor of Cough and Cold Products Barred After Violations

»  Congressional Testimony

NEWS

 

Cream Cheese, Seafood Operations Closed Following Repeat Violations

FDA has announced the shutdown of cream cheese and seafood operations at Illinois-based Lifeway Foods Inc. and its subsidiary, LFI Enterprises Inc., until they comply with food safety laws. The  action follows a history of violations of food and drug law dating back to at least 2004. 

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01835.html 

 

Texas Seafood Processor Ordered to Shut Down, Recall Products

FDA has directed Texas-based Hope Food Supply Inc. to shut down and recall all seafood products manufactured from its facility since 2007. An earlier consent decree required the company to develop and implement an adequate Hazard Analysis and Critical Control Point (HACCP) plan for its fish and fishery products. Because the company has not developed this plan., it cannot restart manufacturing until an FDA-approved HACCP plan is in place. Seafood processors must implement adequate HACCP plans that identify all food safety hazards likely to occur for each kind of seafood product that they process, and set forth preventive measures to control those hazards.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01836.html

 

Maker, Distributor of Cough and Cold Products Barred After Violations

Scientific Laboratories Inc. and two company executives are barred from manufacturing and distributing drug products until they bring their manufacturing operations into compliance with law and obtain approval for their products. Scientific Laboratories is a contract manufacturer and distributor of various prescription cough and cold products. FDA had warned the company against violating food and drug law and about the risk of enforcement action if it failed to take corrective measures.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01837.html

   

CONGRESSIONAL TESTIMONY

May 14 — FDA Center for Food Safety and Applied Nutrition Director Stephen F. Sundlof, D.V.M., appeared before the House Subcommittee on Health

 Subject: “Discussion Draft of the ‘Food and Drug Administration Globalization Act’ Legislation: Device and Cosmetics Safety”

http://www.fda.gov/ola/2008/devices051408.html

 

May 14 — FDA Associate Commissioner for Science Norris Alderson, Ph.D., appeared before the House Subcommittee on Consumer Affairs, Insurance, and Automotive Safety

    Subject: safety of bisphenol-A (BPA)

http://www.fda.gov/ola/2008/bpa051408.html

 

May 14 — FDA Statement for the Record before the House Committee on Oversight and Government Reform

    Subject: “Should FDA Drug and Medical Device Regulation Bar State Liability Claims?”

http://www.fda.gov/ola/2008/stateliability051408.html

To view an archive of past testimony by FDA officials, go to

http://www.fda.gov/ola/listing.html

 

FDA: RLS Treatment Approved. Corn Bread & Muffin Mix Recall

FDA News Digest

May 12, 2008 _____________________________________

IN THIS WEEK’S ISSUE

»  News

    — Generic Versions of Restless Legs Syndrome Treatment Approved

    — FDA OKs Room Temperature Formulation of Blood Clotting Therapy

»  Congressional Testimony

»  Safety Alerts/Recalls

 

NEWS

Generic Versions of Restless Legs Syndrome Treatment Approved

FDA has approved the first generic versions of Requip (ropinirole hydrochloride) tablets for the treatment of moderate-to-severe restless legs syndrome. The approval covers a variety of dosages. Four companies have received approval to market the tablets.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01832.html

 

FDA OKs Room Temperature Formulation of Blood Clotting Therapy

FDA has approved a new formulation of the genetically engineered version of Factor VIIa, used to treat bleeding and prevent surgical bleeding in patients with hemophilia A or B. The new formulation allows the product to be stored at room temperature (up to 77 degrees Fahrenheit) for up to two years. This is helpful for healthcare facilities with limited refrigerated space, and it allows greater flexibility in disease management for both patients and doctors.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01833.html

CONGRESSIONAL TESTIMONY

 

May 1 — FDA Center for Drug Evaluation and Research Director Janet Woodcock, M.D., appeared before the House Subcommittee on Health.

    Subject: “Discussion Draft of The ‘Food And Drug Administration Globalization Act’ Legislation: Drug Safety”

http://www.fda.gov/ola/2008/fdaglobalact050108.html

 

April 29 — FDA Center for Drug Evaluation and Research Director Janet Woodcock, M.D., appeared before the House Subcommittee on Oversight and Investigations.

    Subject: FDA‘s ongoing heparin investigation

http://www.fda.gov/ola/2008/heparin042908.html

  SAFETY ALERTS/RECALLS

Food Recall:

Little Bay Baking and GFCFDiet Corn Bread and Muffin Mix, 12.6-oz. size

Reason for recall: may contain soy not declared on the label

http://www.fda.gov/oc/po/firmrecalls/littlebay05_08.html

For a list of recalls, market withdrawals, and safety alerts involving FDA-regulated

products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.  

 

FDA News: Dog & Cat Food; Laws for Beef; Recall Soymilk

FDA News Digest

April 28, 2008 _____________________________________

IN THIS WEEK’S ISSUE

»  News

n       Pet Food Maker Ordered to Obtain Emergency Operating Permit

n      New Regulation Strengthens Safeguards for Beef Consumers

n      Drug Approved to Treat Bowel Disorder Crohn’s Disease

n        Relistor Approved to Treat Opioid-Induced Constipation

»  Testimony

»  Safety Alerts/Recalls  

__________________________________________

NEWS

Pet Food Maker Ordered to Obtain Emergency Operating Permit

FDA has issued an order requiring that Illinois-based Evanger’s Dog & Cat Food Co. Inc . obtain an emergency permit from FDA before its canned pet food products enter interstate commerce. A recent inspection revealed significant deviations from prescribed documentation, which could result in underprocessed pet foods that can allow the survival and growth of Clostridium botulinum, a bacterium that causes botulism in some animals as well as in humans. For Evanger’s to resume business, the company must document that corrective actions and processing procedures have been implemented to ensure that the finished product will not present a health hazard.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01825.html

 

New Regulation Strengthens Safeguards for Beef Consumers

FDA has issued a final regulation barring certain cattle materials from all animal feed, including pet food. The rule further protects animals and consumers against bovine spongiform encephalopathy (BSE, also known as “mad cow disease”). The new measure builds on FDA’s 1997 feed regulation, which prohibited the use of certain mammalian proteins in ruminant feed.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01823.html

 

 

Drug Approved to Treat Bowel Disorder Crohn’s Disease

FDA has approved Cimzia (certolizumab pegol) to help sufferers of moderate-to-severe Crohn’s disease who have not responded to conventional therapies. Crohn’s disease is a chronic, inflammatory bowel disorder that affects more than 1 million men and women worldwide. It has no cure and its cause is unknown. Patients treated with Cimzia will receive an injection every two weeks for the first three injections. Once benefit has been established, Cimzia should be given once every four weeks.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01821.html

   

Relistor Approved to Treat Opioid-Induced Constipation

FDA has approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients with late-stage, advanced illness who are receiving opioids on a continuous basis to help alleviate their pain. Such patients include those with a diagnosis of incurable cancer, end-stage chronic obstructive pulmonary disease from emphysema, heart failure, Alzheimer’s disease with dementia, HIV/AIDS or other advanced illnesses. Opioids can interfere with normal bowel elimination function by relaxing the intestinal smooth muscles and preventing them from functioning. Relistor acts by blocking opioid entrance into the cells thus allowing the bowels to continue to function normally.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01826.html

  _________________________________

 

TESTIMONY

 

April 25 — FDA Office of Food Safety Deputy Director Don Kraemer appeared before the U.S.-China Economic and Security Review Commission Hearing on “Chinese Seafood: Safety and Trade Issues”

http://www.fda.gov/ola/2008/seafood042408.html

 

April 24 — FDA Center for Food Safety and Applied Nutrition Director Stephen F. Sundlof, DVM, appeared before the House Subcommittee on Health.

    Subject: “Food and Cosmetic Provisions of the ‘Food and Drug Administration Globalization Act’ Discussion Draft Legislation”

http://www.fda.gov/ola/2008/fdaglobalact042408.html

 

April 22 — FDA Commissioner Andrew C. von Eschenbach, M.D., appeared before the House Subcommittee on Oversight and Investigations

    Subject: “FDA Actions to Improve Safety of Medical Products with Foreign Components”

http://www.fda.gov/ola/2008/foreigninspection042208.html

  ___________________________________________________ 

 

SAFETY ALERTS/RECALLS

Drug Recall:

 

Bertek and UDL label Digitek (digoxin tablets, USP, all strengths) for oral use

Reason for recall: tablets may contain twice the approved level of active ingredient

http://www.fda.gov/oc/po/firmrecalls/actavis04_08.html

 

Food Recall:

 

›  Silk Soymilk Chocolate Flavor, 11-ounce plastic single serve bottles printed with both a “use by” date of May 7, 2008 (printed as 05 07 08) and a Universal Product Code (UPC) of 2529360028

Reason for recall: product may contain milk protein not declared on label

http://www.fda.gov/oc/po/firmrecalls/whitewave04_08.html